Stock Research for PHOT

PHOT

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

PHOT Stock Chart & Research Data

The PHOT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PHOT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


PHOT Due diligence Resources & Stock Charts

The PHOT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PHOT Detailed Price Forecast - CNN Money CNN View PHOT Detailed Summary - Google Finance
Yahoo View PHOT Detailed Summary - Yahoo! Finance Zacks View PHOT Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View PHOT Trends & Analysis - Trade-Ideas Barrons View PHOT Major Holders - Barrons
NASDAQ View PHOT Call Transcripts - NASDAQ Seeking View PHOT Breaking News & Analysis - Seeking Alpha
Spotlight View PHOT Annual Report - CompanySpotlight.com OTC Report View PHOT OTC Short Report - OTCShortReport.com
TradeKing View PHOT Fundamentals - TradeKing Charts View PHOT SEC Filings - Bar Chart
WSJ View Historical Prices for PHOT - The WSJ Morningstar View Performance/Total Return for PHOT - Morningstar
MarketWatch View the Analyst Estimates for PHOT - MarketWatch CNBC View the Earnings History for PHOT - CNBC
StockMarketWatch View the PHOT Earnings - StockMarketWatch MacroAxis View PHOT Buy or Sell Recommendations - MacroAxis
Bullish View the PHOT Bullish Patterns - American Bulls Short Pains View PHOT Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View PHOT Stock Mentions - StockTwits PennyStocks View PHOT Stock Mentions - PennyStockTweets
Twitter View PHOT Stock Mentions - Twitter Invest Hub View PHOT Investment Forum News - Investor Hub
Yahoo View PHOT Stock Mentions - Yahoo! Message Board Seeking Alpha View PHOT Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for PHOT - SECform4.com Insider Cow View Insider Transactions for PHOT - Insider Cow
CNBC View PHOT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PHOT - OTC Markets
Yahoo View Insider Transactions for PHOT - Yahoo! Finance NASDAQ View Institutional Holdings for PHOT - NASDAQ


Stock Charts

FinViz View PHOT Stock Insight & Charts - FinViz.com StockCharts View PHOT Investment Charts - StockCharts.com
BarChart View PHOT Stock Overview & Charts - BarChart Trading View View PHOT User Generated Charts - Trading View




Latest Financial News for PHOT


GrowLife, Inc. Reports Increased Backlog and Highlights Positioning for Future Opportunity in Quarterly Filing
Posted on Monday November 16, 2020

Company Files Quarterly Report on Financial and Operations Results from the Period Ending September 30, 2020Summary: * GrowLife shipped $1.4M in revenue for the period * GrowLife reported a $1.9M sales order backlog, not included in revenue * GrowLife increased its blended gross margins to 38.1% for the nine months September 30, 2020, up from 32.5% during the three months ended September 30, 2019 * GrowLife reduced operating expenses for the nine-month period ending September 30, 2020 by $2.8M when compared to the same period in 2019. * GrowLife focused on positioning its EZ-CLONE business, its base business, and its expanding genetics business to benefit from potential legislative change such as federal decriminalization of cannabis KIRKLAND, Wash., Nov. 16, 2020 (GLOBE NEWSWIRE) -- GrowLife, Inc. (OTC: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service providers, today announced financial results for the period ending September 30, 2020 and provided further insight into the company’s positioning as a leader in propagation and genetics for the burgeoning cannabis and hemp industries.The Company shipped $1.4M in revenue and ended with an additional $1.9M backlog of sales for the period ending September 30, 2020. Further, as a result of the cost reduction measures implemented in 2019, the company reported increased gross margins of 38.1% for the nine months September 30, 2020, up from 32.5% during the three months ended September 30, 2019 and a gross profit of $0.5M for the third quarter 2020. Finally, GrowLife reduced its operating expenses by $2.8M during the nine-month period ending September 30, 2020 and reduced cashed used in operations by $0.5M, from $2.0M to $1.5M.“While 2020 has not been without its challenges, I am proud to report that GrowLife continues to generate new sales, especially in our EZ-CLONE business, and further position ourselves to capitalize on the expanding opportunities in legalized hemp as well as the impending legalization of cannabis,” said GrowLife CEO Marco Hegyi. “We recognize that shipping the $1.9M backlog of sales yet unshipped products could have brought us extremely close to profitability. Therefore, we are seeking to scale up production to meet demand by the majority owned EZ CLONE subsidiary. I believe we are taking all the necessary steps to realize this potential for our shareholders as soon as possible.”About GrowLife, Inc.GrowLife, Inc. (PHOT) aims to become the nation’s largest cultivation service provider for cultivating organics, herbs and greens and plant-based medicines. Our mission is to help make our customers successful. Through a network of local representatives covering the United States and Canada, regional centers and its e-Commerce team, GrowLife provides essential goods and services including media, industry-leading hydroponics and soil, plant nutrients, and thousands of more products to specialty grow operations. GrowLife is headquartered in Kirkland, Washington and was founded in 2012.Investor Relations Contact: investors@growlifeinc.com 206-483-0059FORWARD LOOKING STATEMENT:This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of GrowLife, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words may, would, will, expect, estimate, can, believe, potential and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond GrowLife, Inc.’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors.


GrowLife, Inc. Reports Increased Revenue Over Last Quarter and $1 Million in Backlog, in Q2 2020 Financial Results Filing
Posted on Monday August 17, 2020

Company Files Quarterly Report on Financial and Operations Results from the Period Ending June 30, 2020Summary: * GrowLife experienced revenue growth of 11% quarter-over-quarter in second quarter of 2020 as compared to the first quarter of 2020, from $1.7M to $1.8M * GrowLife increased its blended gross margins to 39.3% for the period ending June 30, 2020, up from 30.7% in the same quarter of 2019 * GrowLife reported a $1M sales order backlog, not included in revenue, to be shipped in the third quarter of 2020 and setting a revenue floor for the quarter not previously seen in the company’s history * GrowLife increased gross profit for the quarter to $0.7M, an increase over the same quarter last year * GrowLife reduced operating expenses for the six-month period ending June 30, 2020 by $1.7M when compared to the same period in 2019. * GrowLife experienced increased demand for its commercial line of EZ-CLONE plant propagators fueled by growing demand for CBD-rich hemp and essential classification of cannabis across the countryKIRKLAND, Wash., Aug. 17, 2020 (GLOBE NEWSWIRE) -- GrowLife, Inc. (OTC: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service providers, today announced financial results for the period ending June 30, 2019 and provided an insight into the company’s position in the Management's Discussion and Analysis section of the filing.The Company reported growth in its revenue over the last quarter, reporting $1.8M for the period ending June 30, 2020, an increase of 11% quarter-over-quarter. In addition to the revenue generated, the company also reported a $1M backlog of sales, scheduled to ship in the third quarter 2020, effectively starting the third quarter with a base of $1M in revenue.  Further, as a result of the cost reduction measures implemented in 2019, the company reported increased gross margins of 39.3%, up from 30.7% when compared to the same quarter in 2019 and a gross profit of $0.7M for the second quarter 2020. Finally, GrowLife reduced its operating expenses by $1.7M during the six months ending June 30, 2020 and reduced cashed used in operations by $1.2M, from $2.1M to $0.9M. “While others are pulling back due to the pandemic and other conditions, we are so happy to announce an up quarter where our revenue beat last quarter, we saw further increases in gross margins, and have an outstanding backlog of sales revenue,” said GrowLife CEO Marco Hegyi. “We continued to operate throughout the pandemic as an essential service, providing the equipment necessary for hemp farmers and cannabis operators to continue to plant during the pivotal spring season. Beginning in March, we saw a significant increase in demand for our EZ-CLONE commercial cloning units, one of our highest priced items with attritive margins. This demand resulted in us reporting a one-million-dollar backlog in sales, something extremely noteworthy. This is a key metric I want to highlight,. Even without it, we were able to report quarter-over-quarter growth, and year-over-year increased margins. This is really exciting and the fact that we are growing during these unprecedented times, speaks volumes to how we are positioned as a company.”Q2 2020 FINANCIAL RESULTS               Net Revenue: For the period ending June 30, 2020, GrowLife showed net revenue of $1,849,837, as compared to revenue of $1,661,800 for the period ending March 31, 2020 – an increase of 11.3%.Gross Profit: For the period ending June 30, 2020, GrowLife had Gross Profit of $727,831 as compared to $675,773 the period ending March 31, 2020 – an increase of approximately 7.7%.Net Loss: For the period ending June 30, 2020, GrowLife had a Net Loss of $610,523 as compared to a loss of $1,376,996 for the period ending June 30, 2019.Cash Flow used in Operations: For the six-month period ending June 30, 2020, GrowLife had Cash Flow Used in Operations of $905,804 as compared to $2,097,363 for the same six-month period ending June 30, 2019.About GrowLife, Inc.GrowLife, Inc. (PHOT) aims to become the nation’s largest cultivation service provider for cultivating organics, herbs and greens and plant-based medicines. Our mission is to help make our customers successful. Through a network of local representatives covering the United States and Canada, regional centers and its e-Commerce team, GrowLife provides essential goods and services including media, industry-leading hydroponics and soil, plant nutrients, and thousands of more products to specialty grow operations. GrowLife is headquartered in Kirkland, Washington and was founded in 2012.Public Relations Contact:CMW Media Cassandra Dowell, 858-264-6600 cassandra@cmwmedia.com www.cmwmedia.comInvestor Relations Contact: investors@growlifeinc.com 206-483-0059FORWARD LOOKING STATEMENT:This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of GrowLife, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words may, would, will, expect, estimate, can, believe, potential and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond GrowLife, Inc.’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors.


GrowLife, Inc. Announces Renowned Additions to Advisory Board Focused on Expanding CBD Hemp Starter Business
Posted on Tuesday July 21, 2020

KIRKLAND, Wash., July 21, 2020 -- GrowLife, Inc. (OTCQB: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service.


GrowLife Releases Shareholder Letter from CEO Addressing Market Conditions and Increasing Demand for Consumer CBD Products
Posted on Thursday June 25, 2020

As we previously announced, GrowLife has been fully operational throughout the COVID-19 pandemic in order to serve our customers across the country with our leading line of hemp clones and commercial cloning products. The spring season is a very important time for hemp farmers and with cloning becoming more of the standard in CBD-rich hemp cultivation, it was imperative that we meet the demand for our products without delay.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.